tiprankstipranks
Trending News
More News >
Citius Oncology (CTOR)
NASDAQ:CTOR
US Market

Citius Oncology (CTOR) Financial Statements

Compare
131 Followers

Citius Oncology Financial Overview

Citius Oncology's market cap is currently $93.28M. The company's EPS TTM is $-0.06; its P/E ratio is -3.20; Citius Oncology is scheduled to report earnings on December 23, 2025, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -23.52M$ -20.57M$ -12.12M$ -4.86M
EBITDA$ -23.49M$ -20.57M$ -12.12M$ -4.86M
Net Income$ -24.76M$ -21.15M$ -12.70M$ -5.43M
Balance Sheet
Cash & Short-Term Investments$ 3.92M$ 112.00$ 0.00$ 0.00
Total Assets$ 100.94M$ 84.37M$ 47.73M$ 42.69M
Total Debt$ 3.80M$ 3.80M$ 0.00$ 0.00
Net Debt$ -124.80K$ 3.80M$ -26.52K$ -289.18K
Total Liabilities$ 56.08M$ 38.23M$ 22.20M$ 6.42M
Stockholders' Equity$ 44.87M$ 46.14M$ 25.54M$ 36.27M
Cash Flow
Free Cash Flow$ -11.24M$ -4.87M$ -601.30K$ -47.97K
Operating Cash Flow$ -5.49M$ 126.35K$ -601.30K$ -47.97K
Investing Cash Flow$ -5.75M$ -5.00M$ -1.32M$ -67.32M
Financing Cash Flow$ 15.17M$ 4.87M$ 1.66M$ 67.66M
Currency in USD

Citius Oncology Earnings and Revenue History

Citius Oncology Debt to Assets

Citius Oncology Cash Flow

Citius Oncology Forecast EPS vs Actual EPS